Pharmaceutical products

Contract Value:: GBP 702M -
Notice Type:: Contract Notice

Published Date:: 12 March 2019
Closing Date:: 11 April 2019

Location(s):: UKI LONDON (UK UNITED KINGDOM)

Description:

CM/PHR/16/5515/01 — 1.9.2019 to 31.8.2021 – NHS Framework for the NHS London Region, Branded Medicines – Tranche B with an option to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.

CM/PHR/16/5515/02 — 1.9.2019 to 31.8.2020 — NHS Framework for the NHS London Region, Branded Medicines – Annual Tranche — Cytokine Modulators and other monoclonal antibodies with an option to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months.

CM/PHR/16/5515/03 — 1.9.2019 to 31.8.2020 – NHS Framework for the NHS London Region, Branded Medicines — Antiretrovirals with an option to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months.

NHS Framework for the NHS London Region, Branded Medicines – Tranche B with an Option to Extend (at the Authority’s Discretion) for a Period or Periods up to a Total of 24 Months

Products associated with the lots are listed on Document No. 05 of the Invitation to offer.

Each individual National product code (NPC) pack description in each of the regions (London) is deemed to be a separate product for the application of the award criteria.

There is no restriction on the number of products that bidders can offer for, or be awarded.

The Framework Agreement is intended for use by the Department of Health, Public Health England and the NHS in England.

The framework may also be used by private sector contractors and agents working on behalf of the above

NHS Framework for the NHS London Region, Branded Medicines – Annual Tranche — Cytokine Modulators and other Monoclonal Antibodies with an Option to Extend (at the Authority’s discretion) for a Period

CM/PHR/16/5515/02 — 1.9.2019 to 31.8.2020 — NHS Framework for the NHS London Region, Branded Medicines – annual tranche — Cytokine modulators and other monoclonal antibodies with an option to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months.

Products associated with the lots are listed on document No. 05 of the invitation to offer.

Each individual National Product code (NPC) pack description in each of the regions (London) is deemed to be a separate product for the application of the award criteria.

There is no restriction on the number of products that bidders can offer for, or be awarded.

The Framework Agreement is intended for use by the Department of Health, Public Health England and the NHS in England.

The framework may also be used by private sector contractors and agents working on behalf of the above.

NHS Framework for the NHS London Region, Branded Medicines — Antiretrovirals with an Option to Extend (at the Authority’s Discretion) for a Period or Periods up to a total of 12 months

CM/PHR/16/5515/03 — 1.9.2019 to 31.8. 2020 – NHS Framework for the NHS London Region, Branded Medicines — Antiretrovirals with an option to extend (at the Authority’s discretion) for a period or periods up to a total of 12 months.

Products associated with the lots are listed on Document No. 05 of the Invitation to offer.

Each individual National product code (NPC) pack description in each of the regions (London) is deemed to be a separate product for the application of the award criteria.

There is no restriction on the number of products that bidders can offer for, or be awarded.

The Framework Agreement is intended for use by the Department of Health, Public Health England and the NHS in England.

The framework may also be used by private sector contractors and agents working on behalf of the above.

: Download full details as .pdf

The Buyer:: NHS Commissioning Board (operating under the name of NHS England)

CPV Code(s):: 33600000 - Pharmaceutical products